Stanford University
Showing 16,501-16,600 of 36,216 Results
-
Sara Marie Krzyzaniak
Clinical Professor, Emergency Medicine
BioSara M. Krzyzaniak, MD, is a Clinical Professor of Emergency Medicine at Stanford University School of Medicine and the Program Director for the Stanford Emergency Medicine Residency. She has held progressive leadership roles in undergraduate and graduate medical education since completing her Emergency Medicine residency training at Denver Health Medical Center, with prior faculty appointments at the University of Illinois College of Medicine before joining Stanford.
Dr. Krzyzaniak’s scholarly work focuses on medical education, with particular emphasis on gender equity, assessment and feedback, faculty development, and leadership training within academic medicine. She has authored more than forty peer-reviewed publications, multiple book chapters, and several volumes within the Education Theory Made Practical series. Her academic contributions also include more than one hundred invited national and international presentations.
At Stanford, Dr. Krzyzaniak teaches and mentors across all stages of medical education and holds administrative, curricular, and clinical teaching responsibilities. She serves on numerous institutional and national committees, contributes as an editorial board member and ad hoc reviewer for journals in both emergency medicine and medical education, and maintains an active portfolio of professional service. Her leadership and educational contributions have been recognized through multiple national awards for teaching excellence, mentorship, and program leadership.
Dr. Krzyzaniak’s work is characterized by a sustained commitment to advancing the training of future emergency physicians, strengthening the academic mission of emergency medicine, and contributing to the broader scholarship of medical education. -
Joy Ku
Research Technical Manager, Wu Tsai Human Performance Alliance
Current Role at StanfordJoy Ku is focused on biocomputation and the advancement of their use through teaching, science communications, community building, and the promotion of research resource sharing efforts, particularly as related to reproducibility and open-source science.
She is currently Senior Director of the Wu Tsai Human Performance Alliance at Stanford (https://humanperformance.stanford.edu) and also leads the education and outreach efforts for the overall Wu Tsai Human Performance Alliance, which consists of institutions across the country, including Salk, UC San Diego, the University of Kansas, the University of Oregon, and the Women's Health, Sports & Performance Institute. The Alliance's mission is to discover biological principles to optimize human performance and catalyze innovations in human health.
Dr. Ku is also the Director of Promotions and Didactic Interactions for the NIH-funded Restore Center (https://restore.stanford.edu), as well as the Director of Education and Communications for the Mobilize Center (https://mobilize.stanford.edu), an NIH Biomedical Technology Resource Center. Both Centers provide tools, infrastructure, and training to support the research community. The Mobilize Center's emphasis is on biomechanical modeling and machine learning algorithms to provide new insights into human movement from data sources, such as wearables, video, and medical images. The Restore Center's mission is to advance rehabilitation research using mobile sensor and video technology for real-world assessments of movement and factors affecting movement.
She also manages SimTK (https://simtk.org), a software, model, and data-sharing platform for the biocomputation research community. -
Jing Kuang
Affiliate, Graduate School of Business - Development and External Relations
BioJing Kuang is a venture capitalist and strategic investor who bridges the gap between massive-scale capital markets and the agile world of early-stage innovation. As the Founding Partner at Y Plus Ventures, she focuses on investing in early-stage AI startups in Silicon Valley, helping founders navigate the critical transition from technological breakthroughs to scalable, market-ready business models. Her investment thesis emphasizes the practical application of artificial intelligence and the development of robust infrastructure for the next generation of consumer tech enterprises.
With a deep background in global finance, Jing brings extensive operational and transactional expertise to her portfolio companies. She previously served as President & CEO of Yongjia Capital, where she orchestrated complex financial strategies and cross-border mergers and acquisitions. In this role, she oversaw over $50 billion USD transactions, managing high-stakes deal structuring, due diligence, and strategic integration across distinct market cycles and geographies.
Deeply committed to the educational pipeline of the venture industry, Jing is the Founder and Instructor of the RootedIn VC Fellowship at Stanford. Through this program, she teaches Stanford students in the mechanics of venture capital investment, deal sourcing, decision making and portfolio management. She extends this educational commitment as a Teaching Facilitator for Executive Education at the Stanford d.school, and globally as a Guest Lecturer at the School of Innovation and Entrepreneurship at Peking University, bridging the gap between academic theory and real-world investment practice.
Jing plays a central role in the Stanford ecosystem, serving as Co-President of Stanford GSB Asian Alumni Chapter, President of Stanford GSB Venture Capital Alumni Chapter, and sitting on the Investment Committee for Stanford Angels & Entrepreneurs.
Jing holds an MBA from the Stanford Graduate School of Business and a Bachelor’s degree in Finance from Peking University. -
Kristina Kudelko
Clinical Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
Current Research and Scholarly InterestsDrugs and toxins-associated pulmonary arterial hypertension, clinical outcomes research, evaluating the long-term impacts of a standardized pulmonary vascular disease fellowship training program
-
Ellen Kuhl
Catherine Holman Johnson Director of Stanford Bio-X, Walter B Reinhold Professor in the School of Engineering, Professor of Mechanical Engineering and, by courtesy, of Bioengineering
Current Research and Scholarly Interestscomputaitonal simulation of brain development, cortical folding, computational simulation of cardiac disease, heart failure, left ventricular remodeling, electrophysiology, excitation-contraction coupling, computer-guided surgical planning, patient-specific simulation
-
Joy Kumagai
Ph.D. Student in Biology, admitted Autumn 2022
Other Tech - Graduate, BiologyBioJoy is interested in the ways conservation and disease affect the resilience of coastal foundational species. Her current focus includes studying how seagrasses and kelp forests respond to simultaneous pressures, including marine heatwaves and disease dynamics, and how marine protected areas may affect the resistance and recovery of these ecosystems. She is passionate about useful, transdisciplinary research that increases the wellbeing of people through the sustainable management of marine ecosystems. Using her skillset in GIS, her previous work focused on marine conservation of coastal ecosystems, spanning valuing carbon stocks within Mexico to developing metrics quantifying the extent of area-based conservation. Additionally, she worked for IPBES at the science-policy interface implementing data management within international assessments focused on biodiversity and ecosystem services. When not at her desk, she likes to be out in nature, hiking, swimming, or knitting.
-
Andre Kumar MD, MEd
Clinical Associate Professor, Medicine
BioDr. Andre Kumar is a Clinical Associate Professor in the Stanford Division of Hospital Medicine with a passion for improving patient care through Point-of-Care Ultrasound (POCUS), clinical research, and education. He earned his MD from Tulane University and completed his residency, chief residency, and a Master's in Education at Stanford University.
Dr. Kumar has extensive experience in creating, operationalizing, and leading multi-center clinical trials, including investigations related to POCUS, COVID-19 therapeutics, procedural safety, and the long-term health consequences of infections on the heart and lungs. He continues to conduct research and teach POCUS on a local and national level, and is committed to improving the science and education that underlie the next generation of diagnostic tools. Currently, his research focuses on the impact of artificial intelligence (AI) on numerous healthcare applications, particularly for the improving the accuracy of clinician diagnosis, evidence-based management, and medical imaging.
Dr. Kumar is also a committed educator and mentor to the next generation of physicians. His contributions to medical education have been recognized with several awards, including the Lawrence H. Mathers Award for Exceptional Commitment to Teaching (2023), the Henry J. Kaiser Foundation Award for Excellence in Clinical Teaching (2018, 2022), and the David A. Rytand Clinical Teaching Award (2018, 2022, and 2025). Dr. Kumar has contributed to the creation of educational content, including videos for the Stanford Medicine 25 series that cover various aspects of POCUS.
Dr. Kumar has held numerous leadership positions that reflect his commitment to advancing medical education and clinical practice. He is the Director of the Rathmann Fellowship in Medical Education at Stanford University. In the School of Medicine, he serves as the Co-Director of Clinical Reasoning and Associate Course Director for the Practice of Medicine course. Dr. Kumar is also the Director of the SMART-HM Program, which focuses on faculty development. He is also the Co-Founder and Director of the SHAPE Program in the Stanford Internal Medicine Residency Program.
List of publications: https://bit.ly/3eop95i
ClinicalTrials.Gov registration:
https://bit.ly/2TizOmD
https://bit.ly/2zeNBjJ
Media:
https://shorturl.at/rNU46
https://stanfordmedicine.box.com/s/jm3544zdwpihj6bstcv72x76zq9nuzbq
https://bit.ly/33MZa0O
https://bit.ly/3t8HE2u
https://wb.md/2zfjY1N -
Chirag Kumar
Ph.D. Student in Environment and Resources, admitted Autumn 2025
BioChirag Kumar combines next-generation modeling tools with on-the-ground field research to provide actionable strategies that improve human health amidst environmental and migratory uncertainty. He is interested in causally unraveling the environmental factors driving infectious diseases to inform targeted interventions that mitigate those threats and how those insights can be directly shared with the public to empower individual-level change. To unravel complex human-environment-health systems, he has conducted on-the-ground field work and mechanistic biological analyses to provide key inputs into his models. His findings have been used to advocate for new World Health Organization vaccine recommendations against antimicrobial-resistant pathogens. Chirag previously served as a Biden-Harris US Digital Corps Data Fellow at the US CDC’s Center for Forecasting and Outbreak Analytics and on the Biden administration’s White House AI Forum. He graduated from Princeton University as a Smith-Newton Environmental Research Scholar where he concentrated in chemistry with minors in applied math, global health, and quantitative biology. He is supported by a National Science Foundation Graduate Research Fellowship.
-
Manoj Kumar
Postdoctoral Scholar, Radiology
Current Research and Scholarly InterestsAntibody discovery and characterization | Targeted delivery of genes and drugs | mRNA
therapeutics | Immuno-oncology | CAR-T engineering | Immune profiling | PET/MR imaging -
Parth I Kumar
Affiliate, Department Funds
Fellow in Medicine - Med/NephrologyBioParth Kumar is a fellow in the Stanford University Nephrology Fellowship Program. Dr. Kumar holds a B.A. in Molecular and Cell Biology from UC Berkeley and an M.D. with Distinction from UCSF School of Medicine. He completed his Internal Medicine Residency at UC Irvine, where he was recognized as the Intern Teacher of the Year in 2022. Dr. Kumar's research interests span health care innovation and translational medicine, such as integrating 3D printing into clinical settings to aid patient education, evaluating novel medical devices. His past work includes the study "Evaluating the use of Radioactive Analogs of Doxorubicin for Quantifying ChemoFilter binding and Whole Body PET/MRI Biodistribution," leading to him being recognized as one of the JVIR Editor's Honorees: Distinguished Laboratory Investigations in 2022.
